Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise

Author： Zachos Ioannis   Konstantinopoulos Panagiotis A   Tzortzis Vassilios   Gravas Stavros   Karatzas Anastasios   Karamouzis Michalis V   Melekos Michael   Papavassiliou Athanasios G  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.7, 2010-07, pp. : 875-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiangiogenic Therapy for Metastatic Breast Cancer: Current Status and Future Directions

By Chan Arlene  

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 167-181

Adis International

Access to resources Recommend Favorite

Novel Non-Cytotoxic Therapy in Ovarian Cancer: Current Status and Future Prospects

By Martin Lainie   Schilder Russell J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 955-966

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges

By  

Current Medicinal Chemistry, Vol. 18, Iss. 11, 2011-04 ,pp. : 1599-1612

Bentham Science Publishers

Access to resources Recommend Favorite

Phytochemicals for Breast Cancer Therapy: Current Status and Future Implications

By  

Current Cancer Drug Targets, Vol. 15, Iss. 2, 2015-02 ,pp. : 116-135

Bentham Science Publishers

Access to resources Recommend Favorite

Ovarian Cancer Biomarkers: Current Options and Future Promise

By Coticchia Christine M.   Yang Jiang   Moses Marsha A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 8, 2008-09 ,pp. : 795-802

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite